SCHEMBL6570802

SCHEMBL6570802

NC(=O)c1cc([N+](=O)[O-])c(Cl)c([N+](=O)[O-])c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
PARP1 P09874 1/20 0.58
GPR35 Q9HC97 2/20 0.52
VCAM1 P19320 3/20 0.52
TSHR P16473 3/20 0.50
ALDH1A1 P00352 3/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
HIF1A Q16665 1/20 0.50
TXNRD1 Q16881 1/20 0.50
TXNRD3 Q86VQ6 1/20 0.50
TXNRD2 Q9NNW7 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
LMNA P02545 5/20 0.49
POLB P06746 1/20 0.49
MAPT P10636 1/20 0.48
GAA P10253 1/20 0.47
PKM P14618 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19436436 0.89 CYP3A4 (0.52) CYP3A4SMN1; SMN2PARP1GPR35VCAM1
SCHEMBL19437465 0.87 LMNA (0.53) CYP3A4SMN1; SMN2PARP1GPR35VCAM1
SCHEMBL4324556 0.85 VCAM1 (0.63) CYP3A4PARP1GPR35VCAM1TSHR
SCHEMBL9064336 0.83 CYP3A4 (0.59) CYP3A4SMN1; SMN2PARP1GPR35TSHR
SCHEMBL3146159 0.83 CASP6 (0.60) CYP3A4GPR35VCAM1TSHRALDH1A1
SCHEMBL5674133 0.83 GPR35 (0.52) CYP3A4PARP1GPR35VCAM1TSHR
SCHEMBL3106666 0.83 SMN1; SMN2 (0.59) CYP3A4SMN1; SMN2PARP1VCAM1TSHR
SCHEMBL20876430 0.83 CYP3A4 (0.51) CYP3A4SMN1; SMN2PARP1GPR35VCAM1
SCHEMBL19436450 0.83 MAPT (0.50) CYP3A4SMN1; SMN2PARP1TSHRALDH1A1
SCHEMBL4056647 0.82 SMN1; SMN2 (0.57) CYP3A4SMN1; SMN2PARP1VCAM1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1016405-A2 Arylating medicaments Radopath Pharmaceuticals International Limited (GB) 2000-07-05 EP claimed
CN-1124012-A Arylating medicaments RADOPATH LTD (GB) 1996-06-05 CN claimed
EP-0700287-A1 ARYLATING MEDICAMENTS RADOPATH LIMITED (GB) 1996-03-13 EP claimed
WO-1994027584-A2 ARYLATING MEDICAMENTS RADOPATH LIMITED (GB) 1994-12-08 WO claimed
EP-1109550-B1 NOVEL NITROPHENYLAZIRIDINE COMPOUNDS AND THEIR USE AS PRODRUGS AUCKLAND UNISERVICES LTD (NZ) 2004-11-24 EP disclosed
US-6517836-B1 Aziridin-1-yl nitrobenzamides as prodrugs in conjunction with nitroreductase enzymes AUCKLAND UNISERVICES LIMITED (NZ) 2003-02-11 US disclosed
EP-1016405-A2 Arylating medicaments Radopath Pharmaceuticals International Limited (GB) 2000-07-05 EP disclosed
EP-0700287-A1 ARYLATING MEDICAMENTS RADOPATH LIMITED (GB) 1996-03-13 EP disclosed
WO-1994027584-A2 ARYLATING MEDICAMENTS RADOPATH LIMITED (GB) 1994-12-08 WO disclosed
US-4152510-A AROMATIC DIAMINE CHAIN EXTENDERS BAYER AKTIENGESELLSCHAFT (DE) 1979-05-01 US disclosed